penicillamine has been researched along with gallic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, HA; Keller, WJ; Kinghorn, AD; McLaughlin, JL; Pawlus, AD; Su, BN | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Egerer, K; Hensel, M; Kox, WJ; Mäding, K; Volk, T | 1 |
| Bae, SJ; Choi, HR; Choi, JS; Chung, HY; Han, YN | 1 |
| Iida, H; Inoue, N; Ishida, H; Ishikawa, Y; Yuan, Z | 1 |
5 other study(ies) available for penicillamine and gallic acid
| Article | Year |
|---|---|
Chemical constituents of the fruits of Morinda citrifolia (Noni) and their antioxidant activity.
Topics: Antioxidants; Biphenyl Compounds; Cyclopentane Monoterpenes; Dioxins; Fruit; Glucosides; Iridoids; Molecular Structure; Morinda; Picrates; Plants, Medicinal; Pyrans | 2005 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Intracellular Ca2+ dependence of nitric oxide mediated enhancement of interleukin-8 secretion in human endothelial cells.
Topics: Calcium; Cell Line; Endothelium, Vascular; Fluorescent Dyes; Fura-2; Gallic Acid; Glycine; Humans; Imidazoles; Interleukin-8; Nitric Acid; Nitroprusside; Penicillamine; S-Nitroso-N-Acetylpenicillamine; Tumor Necrosis Factor-alpha | 1997 |
Peroxynitrite scavenging activity of herb extracts.
Topics: Antioxidants; Dose-Response Relationship, Drug; Free Radical Scavengers; Gallic Acid; Hexoses; Molecular Structure; Penicillamine; Peroxynitrous Acid; Plant Extracts; Plants, Medicinal; Spectrometry, Fluorescence | 2002 |
Effect of SNI-2011 on amylase secretion from parotid tissue in rats and in neuronal nitric oxide synthase knockout mice.
Topics: Alkaloids; Amylases; Animals; Azepines; Benzoates; Benzylamines; Calcium; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carbachol; Carbazoles; Chelating Agents; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Enzyme Inhibitors; Estrenes; Gallic Acid; Genotype; Guanylate Cyclase; Imidazoles; In Vitro Techniques; Indoles; Male; Mice; Mice, Knockout; Molsidomine; Muscarinic Agonists; Myosin-Light-Chain Kinase; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oxadiazoles; Parotid Gland; Penicillamine; Phosphodiesterase Inhibitors; Pilocarpine; Protein Kinase Inhibitors; Pyrroles; Pyrrolidinones; Quinoxalines; Quinuclidines; Rats; Rats, Wistar; Sulfonamides; Thiophenes; Type C Phospholipases | 2003 |